Copyright Reports & Markets. All rights reserved.

Global Cancer Biological Therapy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cancer Biological Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Monoclonal Antibodies
    • 1.2.3 Vaccines
    • 1.2.4 Cancer Growth Blockers
    • 1.2.5 Blood Cell Growth Factors
  • 1.3 Market by Application
    • 1.3.1 Global Cancer Biological Therapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Diagnostic Laboratories
    • 1.3.4 Research & Academic Laboratories
    • 1.3.5 Pharmaceutical & Biotechnology Companies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer Biological Therapy Market Perspective (2016-2027)
  • 2.2 Cancer Biological Therapy Growth Trends by Regions
    • 2.2.1 Cancer Biological Therapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Cancer Biological Therapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Cancer Biological Therapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Cancer Biological Therapy Industry Dynamic
    • 2.3.1 Cancer Biological Therapy Market Trends
    • 2.3.2 Cancer Biological Therapy Market Drivers
    • 2.3.3 Cancer Biological Therapy Market Challenges
    • 2.3.4 Cancer Biological Therapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cancer Biological Therapy Players by Revenue
    • 3.1.1 Global Top Cancer Biological Therapy Players by Revenue (2016-2021)
    • 3.1.2 Global Cancer Biological Therapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Cancer Biological Therapy Revenue
  • 3.4 Global Cancer Biological Therapy Market Concentration Ratio
    • 3.4.1 Global Cancer Biological Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Biological Therapy Revenue in 2020
  • 3.5 Cancer Biological Therapy Key Players Head office and Area Served
  • 3.6 Key Players Cancer Biological Therapy Product Solution and Service
  • 3.7 Date of Enter into Cancer Biological Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Biological Therapy Breakdown Data by Type

  • 4.1 Global Cancer Biological Therapy Historic Market Size by Type (2016-2021)
  • 4.2 Global Cancer Biological Therapy Forecasted Market Size by Type (2022-2027)

5 Cancer Biological Therapy Breakdown Data by Application

  • 5.1 Global Cancer Biological Therapy Historic Market Size by Application (2016-2021)
  • 5.2 Global Cancer Biological Therapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Cancer Biological Therapy Market Size (2016-2027)
  • 6.2 North America Cancer Biological Therapy Market Size by Type
    • 6.2.1 North America Cancer Biological Therapy Market Size by Type (2016-2021)
    • 6.2.2 North America Cancer Biological Therapy Market Size by Type (2022-2027)
    • 6.2.3 North America Cancer Biological Therapy Market Size by Type (2016-2027)
  • 6.3 North America Cancer Biological Therapy Market Size by Application
    • 6.3.1 North America Cancer Biological Therapy Market Size by Application (2016-2021)
    • 6.3.2 North America Cancer Biological Therapy Market Size by Application (2022-2027)
    • 6.3.3 North America Cancer Biological Therapy Market Size by Application (2016-2027)
  • 6.4 North America Cancer Biological Therapy Market Size by Country
    • 6.4.1 North America Cancer Biological Therapy Market Size by Country (2016-2021)
    • 6.4.2 North America Cancer Biological Therapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Cancer Biological Therapy Market Size (2016-2027)
  • 7.2 Europe Cancer Biological Therapy Market Size by Type
    • 7.2.1 Europe Cancer Biological Therapy Market Size by Type (2016-2021)
    • 7.2.2 Europe Cancer Biological Therapy Market Size by Type (2022-2027)
    • 7.2.3 Europe Cancer Biological Therapy Market Size by Type (2016-2027)
  • 7.3 Europe Cancer Biological Therapy Market Size by Application
    • 7.3.1 Europe Cancer Biological Therapy Market Size by Application (2016-2021)
    • 7.3.2 Europe Cancer Biological Therapy Market Size by Application (2022-2027)
    • 7.3.3 Europe Cancer Biological Therapy Market Size by Application (2016-2027)
  • 7.4 Europe Cancer Biological Therapy Market Size by Country
    • 7.4.1 Europe Cancer Biological Therapy Market Size by Country (2016-2021)
    • 7.4.2 Europe Cancer Biological Therapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer Biological Therapy Market Size (2016-2027)
  • 8.2 Asia-Pacific Cancer Biological Therapy Market Size by Type
    • 8.2.1 Asia-Pacific Cancer Biological Therapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Cancer Biological Therapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Cancer Biological Therapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Cancer Biological Therapy Market Size by Application
    • 8.3.1 Asia-Pacific Cancer Biological Therapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Cancer Biological Therapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Cancer Biological Therapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Cancer Biological Therapy Market Size by Region
    • 8.4.1 Asia-Pacific Cancer Biological Therapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Cancer Biological Therapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Cancer Biological Therapy Market Size (2016-2027)
  • 9.2 Latin America Cancer Biological Therapy Market Size by Type
    • 9.2.1 Latin America Cancer Biological Therapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Cancer Biological Therapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Cancer Biological Therapy Market Size by Type (2016-2027)
  • 9.3 Latin America Cancer Biological Therapy Market Size by Application
    • 9.3.1 Latin America Cancer Biological Therapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Cancer Biological Therapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Cancer Biological Therapy Market Size by Application (2016-2027)
  • 9.4 Latin America Cancer Biological Therapy Market Size by Country
    • 9.4.1 Latin America Cancer Biological Therapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Cancer Biological Therapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer Biological Therapy Market Size (2016-2027)
  • 10.2 Middle East & Africa Cancer Biological Therapy Market Size by Type
    • 10.2.1 Middle East & Africa Cancer Biological Therapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Cancer Biological Therapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Cancer Biological Therapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Cancer Biological Therapy Market Size by Application
    • 10.3.1 Middle East & Africa Cancer Biological Therapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Cancer Biological Therapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Cancer Biological Therapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Cancer Biological Therapy Market Size by Country
    • 10.4.1 Middle East & Africa Cancer Biological Therapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Cancer Biological Therapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 ELI Lilly
    • 11.1.1 ELI Lilly Company Details
    • 11.1.2 ELI Lilly Business Overview
    • 11.1.3 ELI Lilly Cancer Biological Therapy Introduction
    • 11.1.4 ELI Lilly Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.1.5 ELI Lilly Recent Development
  • 11.2 Sanofi
    • 11.2.1 Sanofi Company Details
    • 11.2.2 Sanofi Business Overview
    • 11.2.3 Sanofi Cancer Biological Therapy Introduction
    • 11.2.4 Sanofi Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.2.5 Sanofi Recent Development
  • 11.3 Merck
    • 11.3.1 Merck Company Details
    • 11.3.2 Merck Business Overview
    • 11.3.3 Merck Cancer Biological Therapy Introduction
    • 11.3.4 Merck Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.3.5 Merck Recent Development
  • 11.4 Bayer
    • 11.4.1 Bayer Company Details
    • 11.4.2 Bayer Business Overview
    • 11.4.3 Bayer Cancer Biological Therapy Introduction
    • 11.4.4 Bayer Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.4.5 Bayer Recent Development
  • 11.5 Roche
    • 11.5.1 Roche Company Details
    • 11.5.2 Roche Business Overview
    • 11.5.3 Roche Cancer Biological Therapy Introduction
    • 11.5.4 Roche Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.5.5 Roche Recent Development
  • 11.6 Novartis International
    • 11.6.1 Novartis International Company Details
    • 11.6.2 Novartis International Business Overview
    • 11.6.3 Novartis International Cancer Biological Therapy Introduction
    • 11.6.4 Novartis International Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.6.5 Novartis International Recent Development
  • 11.7 Pfizer
    • 11.7.1 Pfizer Company Details
    • 11.7.2 Pfizer Business Overview
    • 11.7.3 Pfizer Cancer Biological Therapy Introduction
    • 11.7.4 Pfizer Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.7.5 Pfizer Recent Development
  • 11.8 Bristol-Myers Squibb
    • 11.8.1 Bristol-Myers Squibb Company Details
    • 11.8.2 Bristol-Myers Squibb Business Overview
    • 11.8.3 Bristol-Myers Squibb Cancer Biological Therapy Introduction
    • 11.8.4 Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.8.5 Bristol-Myers Squibb Recent Development
  • 11.9 Seattle Genetics
    • 11.9.1 Seattle Genetics Company Details
    • 11.9.2 Seattle Genetics Business Overview
    • 11.9.3 Seattle Genetics Cancer Biological Therapy Introduction
    • 11.9.4 Seattle Genetics Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.9.5 Seattle Genetics Recent Development
  • 11.10 Amgen
    • 11.10.1 Amgen Company Details
    • 11.10.2 Amgen Business Overview
    • 11.10.3 Amgen Cancer Biological Therapy Introduction
    • 11.10.4 Amgen Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.10.5 Amgen Recent Development
  • 11.11 Takeda Pharmaceuticals
    • 11.11.1 Takeda Pharmaceuticals Company Details
    • 11.11.2 Takeda Pharmaceuticals Business Overview
    • 11.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Introduction
    • 11.11.4 Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.11.5 Takeda Pharmaceuticals Recent Development
  • 11.12 GlaxoSmithKline
    • 11.12.1 GlaxoSmithKline Company Details
    • 11.12.2 GlaxoSmithKline Business Overview
    • 11.12.3 GlaxoSmithKline Cancer Biological Therapy Introduction
    • 11.12.4 GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.12.5 GlaxoSmithKline Recent Development
  • 11.13 Spectrum Pharmaceuticals
    • 11.13.1 Spectrum Pharmaceuticals Company Details
    • 11.13.2 Spectrum Pharmaceuticals Business Overview
    • 11.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Introduction
    • 11.13.4 Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.13.5 Spectrum Pharmaceuticals Recent Development
  • 11.14 Celgene Corporation
    • 11.14.1 Celgene Corporation Company Details
    • 11.14.2 Celgene Corporation Business Overview
    • 11.14.3 Celgene Corporation Cancer Biological Therapy Introduction
    • 11.14.4 Celgene Corporation Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.14.5 Celgene Corporation Recent Development
  • 11.15 AstraZeneca, Plc.
    • 11.15.1 AstraZeneca, Plc. Company Details
    • 11.15.2 AstraZeneca, Plc. Business Overview
    • 11.15.3 AstraZeneca, Plc. Cancer Biological Therapy Introduction
    • 11.15.4 AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.15.5 AstraZeneca, Plc. Recent Development
  • 11.16 Otsuka
    • 11.16.1 Otsuka Company Details
    • 11.16.2 Otsuka Business Overview
    • 11.16.3 Otsuka Cancer Biological Therapy Introduction
    • 11.16.4 Otsuka Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.16.5 Otsuka Recent Development
  • 11.17 Eisai
    • 11.17.1 Eisai Company Details
    • 11.17.2 Eisai Business Overview
    • 11.17.3 Eisai Cancer Biological Therapy Introduction
    • 11.17.4 Eisai Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.17.5 Eisai Recent Development
  • 11.18 Abbvie
    • 11.18.1 Abbvie Company Details
    • 11.18.2 Abbvie Business Overview
    • 11.18.3 Abbvie Cancer Biological Therapy Introduction
    • 11.18.4 Abbvie Revenue in Cancer Biological Therapy Business (2016-2021)
    • 11.18.5 Abbvie Recent Development
  • 11.18 Incyte

.1 Incyte Company Details

    .2 Incyte Business Overview

      .3 Incyte Cancer Biological Therapy Introduction

        .4 Incyte Revenue in Cancer Biological Therapy Business (2016-2021)

          .5 Incyte Recent Development

            12 Analyst's Viewpoints/Conclusions

              13 Appendix

              • 13.1 Research Methodology
                • 13.1.1 Methodology/Research Approach
                • 13.1.2 Data Source
              • 13.2 Disclaimer

              Cancer Biological Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biological Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

              Segment by Type
              Monoclonal Antibodies
              Vaccines
              Cancer Growth Blockers
              Blood Cell Growth Factors

              Segment by Application
              Hospitals
              Diagnostic Laboratories
              Research & Academic Laboratories
              Pharmaceutical & Biotechnology Companies

              By Region
              North America
              U.S.
              Canada
              Europe
              Germany
              France
              U.K.
              Italy
              Russia
              Nordic
              Rest of Europe
              Asia-Pacific
              China
              Japan
              South Korea
              Southeast Asia
              India
              Australia
              Rest of Asia
              Latin America
              Mexico
              Brazil
              Rest of Latin America
              Middle East & Africa
              Turkey
              Saudi Arabia
              UAE
              Rest of MEA

              By Company
              ELI Lilly
              Sanofi
              Merck
              Bayer
              Roche
              Novartis International
              Pfizer
              Bristol-Myers Squibb
              Seattle Genetics
              Bayer
              Roche
              GlaxoSmithKline
              Spectrum Pharmaceuticals
              Celgene Corporation
              AstraZeneca, Plc.
              Otsuka
              Eisai
              Abbvie

              Buy now